ArticleDiabetology & metabolic syndrome2025
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and gout in US adults: a cross-sectional study of the mediating role of BMI.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe connection between non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) and gout has been documented among American adults; however, the specific mechanisms underlying this relationship remain to be elucidated. This cross-sectional study aimed to explore the mediating role of Body mass index (BMI) in the relationship between NHHR and gout prevalence among US adults, using the National Health and Nutrition Examination Survey (NHANES) data.
methodsParticipants were drawn from the NHANES across four cycles for this cross-sectional analysis. NHHR is characterized by the proportion of cholesterol that is non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol. We employed bootstrapping-based mediation analysis to assess the impact of NHHR on gout risk mediated by BMI.
resultsThe prevalence of gout in our study was found to be 5.07%. Multivariate logistic regression analysis identified a significant correlation between NHHR and the likelihood of developing gout (OR = 1.13, 95%CI 1.06-1.20, p = 0.001). Mediation analysis indicated that the relationship between NHHR and gout risk was partially mediated by BMI, accounting for 26.27% (95% CI 10.96-57.95%; p < 0.0001; total effect = 0.0076, direct effect = 0.0056) of the association.
conclusionBMI significantly mediates part of the relationship between NHHR and gout among American adults, underscoring the need to factor in body weight when comprehending gout risk elements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.